Skip to Content


In the US, Sucralfate (sucralfate systemic) is a member of the drug class miscellaneous GI agents and is used to treat Duodenal Ulcer, Duodenal Ulcer Prophylaxis, GERD, Hyperphosphatemia of Renal Failure, Stomach Ulcer, Stomatitis and Stress Ulcer Prophylaxis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of peptic ulcer

Protectant of gastrointestinal mucosa

Chemical Name

Sucrose hydrogen sulfate basic aluminium salt

Foreign Names

  • Sucralfatum (Latin)
  • Sucralfat (German)
  • Sucralfate (French)
  • Sucralfato (Spanish)

Generic Names

  • Sucralfate (OS: BAN, USAN, DCF)
  • Sucralfato (OS: DCIT)
  • CGA-6J (IS)
  • OS 202 (IS)
  • Sucralfat (PH: Ph. Eur. 8)
  • Sucralfate (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Sucralfatum (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.